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 ABSTRACT 
BACKGROUND AND OBJECTIVE 
 
Several scoring systems have been used in the past to assess severity 
and outcome in acute pancreatitis. 
To assess the ability of the BISAP score to predict which patients are at 
risk for intermediate markers of severity including the development of organ 
failure, persistent organ failure and pancreatic necrosis. 
METHODS 
 
A prospective study was done between November 2014 to June 2015. 50 
patients who presented to Government Royapettah Hospital and diagnosed as 
acute pancreatitis were included in the study. Full history, clinical examination, 
ultrasound abdomen and laboratory blood test were done for all patients and 
BISAP score assigned for all patients with acute pancreatitis. 
RESULTS 
 
90 % were found to be males 96% of patients were presented with 
abdominal pain as chief complaint .Mean length of hospital stay was found to be 
13.98 days. Alcohol was found to be the commonest cause of acute pancreatitis, in 
54% of patients. 
BISAP score was found to have high sensitivity (80%) and specificity 
(88.89%) in predicting necrosis, and high sensitivity (83.33%) and specificity   
 (90%) in predicting organ failure. Sensitivity and specificity in predicting 
mortality was found to be 100% and 95.83 % respectively. 
CONCLUSION 
BISAP scoring is a simple and bedside scoring system with high sensitivity 
and specificity in predicting disease severity in terms or necrosis, organ failure 
and mortality. 
KEY WORDS 
 Acute pancreatitis, BISAP 
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INRODUCTION 
Acute pancreatitis is a relatively common and a potentially life threatening 
disease. It is defined as “an inflammatory process of pancreas with possible 
peripancreatic tissue involvement and multi organ dysfunction syndrome with 
increasing mortality rate”1 
Estimates of incidence are often inaccurate, because mild cases are often 
unreported, and deaths may occur in severe forms even before a diagnosis is 
made.  
Severe acute pancreatitis accounts for about 20 % of the cases, and it is associated 
with one or more of the following: Pancreatic necrosis, distant organ failure, and 
development of local complications like haemorrhage, pancreatic necrosis, 
pseudocyst etc. Mortality in severe acute pancreatitis is 15-30 % and is only 0-1 
% in case of mild acute pancreatitis.2 
The exact mechanism of pathophysiology of acute pancreatitis is not 
clearly known, but has been attributed to abnormal activation of pancreatic 
enzymes within the acinar cells. Co-localization of zymogen granules and 
lysosomes occur resulting in activation of the enzymes, which results in auto-
digestion of pancreas. In response to initial insult, acinar cells release pro-
inflammatory cytokines, such as TNF a, IL-1, 2 and 6, and anti-inflammatory 
mediators such as IL-10 and IL-1 receptor antagonist.3 
These mediators then propagate the response systemically as well as locally. The 
local response increases the permeability and alters the microcirculation and 
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worsens the disease process. However the inflammatory response is self-limited in 
most of the patients, but a vicious cycle of pancreatic injury and local and 
systemic inflammation persists in severe forms. 
Acute pancreatitis can be classified as mild and severe form. Mild acute 
pancreatitis is characterised by interstitial edema of the gland and is usually a self-
limiting disease. Whereas in the severe form, there is pancreatic necrosis, sever 
systemic inflammatory response and multi – organ failure which can lead to 
death. Hence it is prudent to identify risk stratification tools for the disease, which 
help in the management. 
Various criterial of severity stratification have been developed to define the 
severity of the disease in the past. The earliest of which was developed by Ranson 
and colleagues in 19744. It predicts the severity of the disease, which is based on 
11 parameters that are obtained at the time of admission and after 48 hours. 
Ransons’s score has a low positive predictive value (50%) and a high negative 
predictive value (90%). Hence its main use is to rule out acute pancreatitis and 
also predicts a severe attack5. The major disadvantage Ranson’s and as well as 
older Glasgow criteria being, many of the parameters which are components of 
this scoring, are not collected at admission, on a routine basis. Also, it does not 
predict the severity of the disease at admission, as six of the parameters are 
assessed only after 48 hours. Hence an early therapeutic window is missed. 
The APACHE II, which is the most common scoring used worldwide, was 
originally developed as a risk stratification tool in intensive care setting. But it 
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takes into account a huge list of parameters, some of which may not be related to 
the severity. 
Hence, an accurate, and relatively simple bedside scoring system BISAP 
was developed. This scoring system identifies patients with high morbidity as well 
as risk of mortality, before organ failure sets in. Data for this scoring system is 
collected within 24 hours of hospitalization, which helps in identifying patients 
who are risk of developing a severe disease  very early, and helps in managing the 
same effectively, thus decreasing the mortality and morbidity. 
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AIMS AND OBJECTIVES OF THE STUDY 
 
 To evaluate the ability of BISAP score to predict mortality in acute 
pancreatitis patients from our institution 
 To assess the ability of the BISAP score to predict which patients are at risk 
for intermediate markers of severity including the development of organ 
failure, persistent organ failure and pancreatic necrosis. 
 To correlate the outcome of the study with the scores observed, in 
terms of disease severity and mortality. 
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REVIEW OF LITERATURE 
 
HISTORY 
 
The pancreas was generally ignored in antiquity, both as an organ and as a 
seat of disease. 
The pancreas was first discovered by Herophilus, a Greek anatomist cum 
surgeon, born in 336 BC on the Asiatic side of the Bosporus in Chalcedon6. 
The word pancreas first mentioned in the writings of  Eristratos (310-
250B.C.). The Four hundred years later, Rufus, (1st or 2nd Century AD), an 
anatomist cum surgeon of Ephesus, gave the name “pancreas”. Written in Greek 
language, the word meant “pan: all, kreas: flesh” 
Galen (Claudius Galenus 138-201 AD), “Physician to the Gladiators” of 
Rome& the Roman Emperor, taught that the pancreas serves as a cushion to 
protect the large blood vessels lying behind it7. 
In March 2, 1642, a German émigré, Johann Georg Wirsung, discovered 
the pancreatic duct at San Francisco Monastery in Padua, Italy. But it was named 
by his colleague as “The Duct of Wirsüng”8. 
Whereas papilla, the enlargement of that duct at its junction with the 
common bile duct (CBD) which projects into the second part of duodenum, were 
first described by Vater in 1720.  
Santorini, in 1734, described the accessory duct that bears his name In 
1869, Paul Langerhans (“Junior”), a student of the famous Berlin Institute of 
Pathology, headed by the eminent Professor Rudolph Virchow, described the 
islets of the pancreas that was subsequently known as the “islets of Langerhans”, 
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an endocrine system which lies within the pancreas. This was the first good 
histologic description of the pancreas. 
In 1893, Laguesse suggested that the islet cells produce a hormone. In 1909 
Jean de Meyer suggested the name 'insulin' for this hormone. 
Eugene Lindsay Opie (1873-1971) was able to show the association 
between diabetes and failure of the islet cells and in 1901, proposed his “common 
channel” hypothesis9. 
 
GROSS ANATOMY 
The term “Pancreas” is derived from the Greek word Pan Kreas, meaning 
“all flesh”6. The fascinating embryological development of the Pancreas has 
intrigued the biologists. It is an endodermally derived organ, consisting of two 
morphologically different parts, the exocrine and the endocrine tissue10. It has also 
been described as “two organs in one”, in view of the distinct function of the 
gland. 
It is a posteriorly situated retroperitoneal organ, lying posterior to the 
stomach, sloping upward from the C-loop of the duodenum to the splenic hilum at 
the level of L1.The fact that the pancreas is situated so deeply in the abdomen, 
and is sealed in the retroperitoneum explains the poorly localized and sometimes 
ill-defined nature with which pancreatic pathology presents. 
It consists of head, neck, body and tail, with one accessory lobe or the 
“uncinate process”. 
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The pancreas is 15-20 cm in length, with a mean weight of 91.8 g (range, 
40.9 to 182 g). 
The head of the pancreas lies to the right of midline, within the C loop of 
the duodenum, posterior to transverse mesocolon, and immediately anterior to the 
inferior vena cava at the confluence of the renal veins. 
The uncinate process extends from the head of the pancreas, behind the 
superior mesenteric vein and terminates near the superior mesenteric artery. 
The neck lies directly over the portal vein and vertebral bodies L1 and L2, 
where the splenic and superior mesenteric veins unite to form the portal vein.  The 
inferior mesenteric vein may join the superior mesenteric vein or merge with the 
superior mesenteric-portal venous junction to form a trifurcation. The superior 
mesenteric artery lies parallel to, and just to the left of superior mesenteric vein. 
The body and tail of the pancreas then extend across the midline, anterior 
to splenic artery and vein, and anterior to Gerota’s fascia and slightly cephalad, 
terminating within the splenic hilum. 
The capsule of the pancreas is loosely attached to its surface and is 
contiguous with the anterior layer of mesocolon, and it can be dissected in 
continuity. 
BLOOD SUPPLY 
ARTERIAL SUPPLY 
The major blood supply of the pancreas comes from, multiple branches of 
the celiac trunk and superior mesenteric arteries, which form arterial arcades 
within the body and tail of the pancreas. The splenic and common hepatic arteries 
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arise from the celiac trunk. The dorsal and greater pancreatic arteries branch from 
the splenic artery, whereas the gastroduodenal artery branches from the common 
hepatic artery, then dividing around the head of the pancreas into anterior and 
posterior superior pancreaticoduodenal branches that anastomose with the anterior 
and posterior branches of the inferior pancreaticoduodenal artery, which are 
branches of the superior mesenteric artery. 
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ARTERIAL SUPPLY 
 
 
 
 
 
 
 
 
 
Figure 1: Arterial Supply 
 
The head of the pancreas and its uncinate process are supplied by the 
pancreatico-duodenal arteries. The neck, body, and tail receive blood supply from 
the splenic artery. Many small branches arise from the length of the splenic artery, 
supplying arterial blood flow to the superior part of the organ. The splenic artery, 
branches to give the dorsal pancreatic artery, which courses posterior to the body 
of the pancreas, to become the inferior pancreatic artery. The inferior pancreatic 
artery then runs along the lower border of the pancreas, terminating at the tail. 
Venous drainage of the pancreas is mainly into the portal system, with the 
head and neck draining primarily through the superior and inferior pancreatico-
duodenal veins, and the body and tail drain into the splenic vein. 
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VENOUS DRAINAGE 
 
 
 
 
 
 
 
 
Figure 2: Venous Drainage 
Venous drainage of the pancreas mimics its arterial supply. Head of the 
pancreas drains into the anterior and posterior pancreatico-duodenal veins. The 
posterior-superior pancreatico-duodenal vein enters the superior mesenteric vein, 
laterally at the superior border of neck of the pancreas. The anterior and postero-
inferior pancreatico-duodenal veins enter the superior mesenteric vein, along the 
inferior border of the uncinate process. Body and tail of pancreas are drained via 
the splenic venous system. 
  
11  
LYMPHATIC DRAINAGE 
 
 
 
 
 
 
 
Figure 3: Lymphatic Drainage 
The lymphatic drainage from the pancreas is diffuse and widespread. The 
lymphatics of pancreas, in general, drain the surface network of lymph toward 
regional lymph nodes and are formed near the larger blood vessels11.The superior 
lymphatics, run along the superior border of the pancreas closely with the splenic 
blood vessels. Those on the left side of the body and tail of pancreas, empty into 
lymph nodes in the hilum of spleen. Those on the right side of the body and the 
neck of pancreas, empty into lymph nodes near the superior border of the head. 
They also receive tributaries from the anterior and posterior surfaces of the 
pancreas. The inferior lymphatics along inferior pancreatic artery. Those that 
drain the left lower side of the body and tail of the pancreas, drain towards the 
lymph nodes in the splenic hilum. The remaining areas of the neck and body of 
the pancreas drain towards the right. The profuse network of lymphatic vessels 
and lymph nodes draining the pancreas provide egress to tumour cells arising 
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from the pancreas. This diffuse  lymphatic drainage contributes to the fact that 
pancreatic cancer often presents with positive lymph nodes and a high incidence 
of local recurrence after resection. Lymph nodes can be palpated along the 
posterior aspect of the head of the pancreas in the pancreaticoduodenal groove, 
where the mesenteric vein passes below the neck of the pancreas, along the 
inferior border of the body, along the hepatic artery ascending into the porta 
hepatis, and along the splenic artery and vein. The pancreatic lymphatics also 
communicate with lymph nodes in the transverse mesocolon and mesentery of the 
proximal jejunum. 
DUCTAL ANATOMY OF PANCREAS 
The main pancreatic duct or the duct of Wirsung, beginning in the distal 
tail of pancreas as a confluence of small anastomosing ductules draining the 
lobules of the gland. The duct runs through the body of pancreas to the head, 
midway between the superior and inferior border of the gland and slightly 
posterior, where it usually passes downward and backward in close juxtaposition 
to the common bile duct. 
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Figure 4: Ductal Anatomy 
 
 
 
 
 
 
 
 
 
 
 
In the head of the pancreas, the pancreatic duct turns inferiorly at the genu 
of the pancreatic duct and joins the common bile duct, draining into the duodenum 
at the ampulla of  Vater, 7 to 10 cm distal to the pylorus. The main pancreatic duct 
is widest at the head of the pancreas (5mm), and the duct gradually tapers as it 
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progresses to the body (4mm) and tail (3mm).At the level of the ampulla of  
Vater, the pancreatic duct is anterior and inferior to the common bile duct. There 
are over 20 secondary branches of the duct of Wirsung throughout the pancreas, 
which drain the acinar units. The main pancreatic duct is 2 to 4 mm in diameter 
and has a ductal pressure of approximately 15 to 30 mm Hg. This is higher than 
the pressure in the common bile duct, 7 to 17 mm Hg, thereby preventing reflux 
of bile into the pancreatic ductal system. At the level of the major papilla, the duct 
turns horizontally to join, in most cases with the bile duct. This short common 
segment is the ampulla of the bile duct, which terminates at the duodenal papilla. 
The papilla of Vater at the termination of the common bile duct is a small, nipple 
like structure that protrudes into the duodenal lumen and is marked by a 
longitudinal fold of duodenal mucosa. Approximately 70% of the general 
population have a patent accessory duct (of Santorini), which is also known as the 
“minor duct”. The accessory pancreatic duct, or duct of Santorini, is more 
variable than the main pancreatic duct. It typically drains the uncinate process and 
inferior portion of the pancreatic head into the duodenum at the minor papilla, 
proximal to the ampulla of Vater fold of duodenal mucosa. The accessory 
pancreatic duct lies anterior to the bile duct, and drains into the minor papilla, 
which lies proximal to the ampulla of Vater, but is also located in the second part 
of the duodenum. 
  
15  
NERVE SUPPLY 
 
 
 
 
 
     
 
 
 
Figure 5: Nerve Supply 
The visceral efferent innervation of the pancreas is through the vagi and the 
splanchnic nerves by way of the hepatic and celiac plexuses. The efferent fibers of 
the vagi, pass through these plexuses without synapsing, and they terminate in 
parasympathetic ganglia in the interlobular septa of the pancreas. The 
postganglionic fibers innervate acini, islets, and the ducts. The acinar cells which 
are responsible for exocrine secretion, the islet cells which are responsible for 
endocrine secretion, and the islet vasculature, are innervated by both the systems. 
The bodies of the preganglionic neurons of these sympathetic efferent neurons, 
originate in the lateral gray matter of the thoracic and the lumbar spinal cord. The 
bodies of the postganglionic sympathetic neurons are located in the great plexuses 
of the abdomen. Their postganglionic fibers innervate only the blood vessels. The 
autonomic fibers, are located near the blood vessels of the pancreas. 
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The parasympathetic system stimulates endocrine and exocrine secretion, 
and the sympathetic system inhibits secretions. The pancreas is also innervated by 
neurons which secrete amines and peptides, such as somatostatin, vasoactive 
intestinal peptide, calcitonin gene-related peptide and galanin. The exact role of 
these neurons in pancreatic physiology is not clear. 
The pancreas also has a rich supply of afferent sensory fibers, which are 
responsible for the intense pain associated with advanced pancreatic cancer, as 
well as acute and chronic pancreatitis12.These somatic fibers travel to the celiac 
ganglion. 
EMBRYOLOGY 
 
 
 
     
 
 
 
Figure 6: Embryology 
The embryonic pancreas is known to pass through three stages of 
development13.The first is the undifferentiated stage, in which the endoderm 
evaginates to initiate pancreatic morphogenesis, with only insulin and glucagon 
genes being expressed. The second stage, involves epithelial branching with 
formation of primitive ducts. The final stage begins with formation of acinar cells 
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at the apex of the ductal structures, with development of zymogen granules which 
contain enzymes. Acinar cells usually begin enzyme secretion only shortly after 
birth. 
The pancreas arises from the posterior foregut endoderm. Initially two 
dorsal and one ventral, and then migrate towards one another, and fuse to form a 
single unit. After about one month of gestation, the foregut evaginates into a 
condensation of the overlying mesenchyme to form the first morphologic dorsal 
bud.  About one week later, one ventral bud forms. Both buds undergo elongation 
of a stalk and branching. At 37 to 42 days of gestation, ventral pancreas rotates 
around the duodenum, and fuses with dorsal pancreas. 
The dorsal pancreas forms the body, tail, and the superior part of the 
pancreatic head, along with the distal part of the main pancreatic duct (of 
Wirsung),and the entire minor accessory pancreatic duct (of Santorini). The 
ventral pancreas forms the uncinate process, and the inferior part of the head of 
the pancreas. It also forms the proximal part of the main pancreatic duct. The two 
duct systems corresponding to the ventral and dorsal buds, fail to fuse in to 10% 
of the general population. This leads to a condition called pancreas divisum, in 
which the accessory pancreatic duct, functions as the main route for drainage and 
enters the duodenum via major papilla, whereas a dorsal pancreatic duct enters 
through a minor papilla, which is slightly proximal. 
As most of the pancreatic exocrine secretions exit via the dorsal duct, 
pancreas divisum can lead to partial obstruction caused by a small minor papilla, 
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resulting in chronic backpressure within the duct. This can lead to acute on 
chronic pancreatitis. 
 Failure of the ventral pancreas to fully rotate around the duodenum leads 
to a condition called annular pancreas, which leads to circumferential or near-
circumferential pancreatic tissue surrounding the second part of the duodenum. 
HISTOLOGY 
The pancreas is a compound, finely nodular gland. The lobules are visible 
on gross examination, and are connected by connective tissue septa which contain 
the ducts, blood vessels, lymphatics, and the nerves. The basic subunit of the 
exocrine part is the acinus, which is at its base a spherical mass of secretory cells 
called acinar cells. The spherical acinus connects to a goblet-shaped neck that 
consists of tubular cells called duct cells. The inner lumen of the acinus forms the 
terminal portion of the secretory duct. The pancreatic ductal system is lined by 
columnar epithelium. Goblet cells and occasional argentaffin cells are also 
present. The larger ducts are thick walled, consisting of connective tissue and 
elastic fibers. The endocrine part consists of the islets of Langerhans cell. In the 
resting state, numerous eosinophilic zymogen granules fill the apical part of the 
cell. The basal part of the cells contain 1 or 2 centrally located, spherical nuclei 
and basophilic. 
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Figure 7: Histology 
 
PANCREATIC SECRETIONS 
EXOCRINE 
The functional unit of the exocrine pancreas is composed of an acinus and 
its draining ductile. The acini are designed to produce, store, and secrete digestive 
enzymes. There are receptors for hormones and neurotrasmitters which stimulate 
release of enzymes, located at the basolateral aspect of acinar cell membrane. 
COMPOSITION OF EXOCRINE SECRETIONS 
The pancreas secretes approximately 500 to 800 mL per day of colorless, 
odorless, alkaline, isosmotic pancreatic juice. Pancreatic juice is a combination of 
acinar and ductal secretions. The acinar cells secrete amylase, proteases, and 
lipases, which are responsible for digestion of carbohydrates, proteins, and fat. 
 The predominant inorganic components of pancreatic exocrine secretions 
will include, water, sodium, potassium, chloride, and bicarbonate. Water and ion 
secretions deliver digestive enzymes to the intestinal lumen help to neutralize 
gastric acid which is emptied into the duodenum. 
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 Pancreatic juice which is released on stimulation with secretinis “clear, 
colourless, alkaline, and isotonic with plasma”. The flow rate increases from an 
average of 0.2 or 0.3 mL/min in the resting state to 4.0 mL/min during post 
prandial stimulation. A volume of 2.5 L is secreted per day. 
Secretin stimulates secretion by binding to its receptor on the basolateral 
membrane of the duct cell, thus activating adenylate cyclase and increasing cyclic 
adenosine monophosphate (cAMP); acetylcholine does so by binding to its 
receptor and raising intracellular calcium concentrations. 
ORGANIC CONSTITUENTS 
The human pancreas has a large capacity for synthesizing protein (mostly 
digestive enzymes). 
 
Amylases digest the carbohydrates (starch and glycogen) by hydrolyzing 1,                 
4-glycoside linkages at every other junction between carbon 1 and oxygen. The 
products of amylase digestion are maltose and maltotriose and α-dextrins. The 
brush border enzymes of the enterocyte complete hydrolysis of theseto glucose. 
The pancreas secretes three lipases:  
1. Lipase (or TG lipase) 
2. Phospholipase A2,  
3. Carboxylesterase 
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Pancreatic lipase hydrolyzes a TG molecule to 2 fatty acid molecules 
released from carbons 1 and 3 and a monoglyceride with a fatty acid esterified to 
glycerol at carbon 2. Colipase is believed to form a complex with lipase and bile 
salts. 
Proteases: Trypsin converts the pro-enzymes secreted by the pancreas to an 
active form, in the duodenum. Trypsinogen is converted to its active form, trypsin, 
by enterokinase, which is secreted by the duodenal mucosal cells. Failure to 
express trypsinogen inhibitor, pancreatic secretory trypsin inhibitor (PSTI) or 
SPINK1, is a cause of familial pancreatitis. Trypsinogen is expressed in several 
isoforms, and a missense mutation on the cationic trypsinogen, or PRSS1, results 
in premature and intra-pancreatic activation of trypsinogen causing hereditary 
pancreatitis. Trypsin, chymotrypsin, and elastase are endopeptidases that cleave 
specific peptide bonds adjacent to specific amino acids. The combined actions of 
gastric pepsin and the pancreatic proteases result in the formation of oligopeptides 
and free amino acids. The oligopeptides can be further digested by enterocyte 
brush-border enzymes 
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Figure 8: Pancreatic Secretion 
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PHYSIOLOGY 
Exocrine secretion of the pancreas occurs during the fasting state and after 
ingestion of a meal. 
The inter-digestive pattern of secretion begins with the clearance of food from the 
upper gastrointestinal tract. 
The inter-digestive phase of pancreatic secretion is in a cyclical fashion, and 
follows the pattern of the “migrating myoelectric complex” or MMC. 
The pattern repeats once in 1-2 hours, with periods of increased secretion of 
enzymes, during periods of increased motor activity in the stomach and the 
duodenum. 
Exocrine pancreatic secretion with ingestion of food is divided into 3 phases:  
1. Cephalic 
2. Gastric 
3. Intestinal 
CEPHALIC PHASE  
Cephalic phase of pancreatic secretion is vagally mediated. Cephalic 
stimulation increases acinar secretion within the pancreas, and a decreased pH in 
the duodenum increases acinar secretion and bicarbonate production by the duct. 
GASTRIC PHASE 
The gastric phase is due to a meal in the stomach. Distension of stomach is 
an important stimulus, which results in predominant enzyme secretion with 
minimal secretion of water and bicarbonates. 
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INTESTINAL PHASE 
It is mediated by hormones and entero-pancreatic vagovagal reflexes. In 
contrast to the cephalic and gastric phases, there is significant ductal secretion 
during the intestinal phase. Ductal secretion is initiated by hydrogen ions in the 
intestinal lumen. Secretin is released from entero-endocrine S cells in the 
duodenal mucosa when the pH of the lumen is less than 4.514. The amount of 
secretin that is secreted as well as the volume of pancreatic secretion is based on 
the load of “titratable acid” delivered to the duodenum. The mediators of the 
enzyme secretory response from intestinal stimuli are neural and humoral. 
Cholecystokinin is the most important humoral mediator of enzyme secretion 
during the intestinal phase. Level of CCK usually increases following a meal. 
The amount of bicarbonate secreted varies with pancreatic secretory rate, 
greater concentrations of bicarbonate being secreted in high pancreatic secretory 
rates. Secretion of chloride varies inversely with bicarbonate secretion, and the 
sum of these two remains constant. However, sodium and potassium 
concentrations are constant in all secretory rates 
 
 
 
 
 
 
Figure 9: Regulation of Secretion 
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ENDOCRINE SECRETIONS 
There are over a million islets of Langerhans in the adult pancreas. They 
vary in size from 40 to 900 nm. Larger ones are located near major arterioles, and 
smaller ones are embedded more deeply within the parenchyma of the gland. 
Most islets contain, 5 cell types 
Alpha Cells: Secrete glucagon, Opposite effects of insulin; increased hepatic 
glycogenolysis and gluconeogenesis 
Beta Cells: Secrete insulin, Decreased gluconeogenesis, glycogenolysis, fatty 
acid breakdown, and ketogenesis, Increased glycogenesis, protein synthesis 
Delta Cell: Secrete Somatostatin, Inhibits GI secretion, secretion and action of all 
GI endocrine peptides, Inhibits cell growth 
Epsilon Cells: Secrete ghrelin, Decreases insulin release and insulin action 
PP Cells: Secrete Pancreatic Polypeptide, Inhibits pancreatic exocrine secretion 
and section of insulin,  facilitates hepatic effect of insulin 
ACUTE PANCREATITIS 
DEFINITION 
Pancreatitis is an “inflammation of glandular parenchyma lead to injury or 
destruction of acinar components associated with little or no fibrosis of the 
pancreas”. 
Acute pancreatitis is best diagnosed clinically in a patient presenting with 2 of the 
3 following criteria15. 
(1) Symptoms consistent with pancreatitis, 
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(2) Serum lipase or amylase levels more than 3 times the laboratory’s upper 
range of normal, and 
(3) Radiologic features suggestive of pancreatitis, usually using CECT 
Usually, the first two criteria are present, and CECT is not required for 
diagnosis. 
The most common cause of acute pancreatitis is gallstones, in 
approximately 50% of the patients, followed by alcohol in 20%16. In a study done 
in New Delhi, India, gall stones and alcoholism were found to be the cause in 
49% and 23.6% cases, respectively14. 
The remaining 10% form a rather large group of other causes of acute 
pancreatitis. These include hypercalcemia, hypertriglyceridemia, medications, 
hereditary causes, sphincter of Oddi dysfunction, pancreatic neoplasms, pancreas 
divisum and others. 
ETIOLOGY 
GALL STONES 
Obstructive cause of acute pancreatitis is most frequently due to gallstones. 
However, only 3% to 7% of patients who have gallstones, will develop an attack 
of acute pancreatitis in their lifetime. Gallstone pancreatitis is more common in 
women than men because gallstones are more frequent in women17. Acute 
pancreatitis occurs more commonly when a patient harbours a smaller stone, less 
than a diameter of 5mm, as they are more likely large stones to traverse down the 
cystic duct to go on to obstruct the ampulla. Intermittent and continuous 
obstruction of the ampullary orifice due to a gallstone or edema induced by stone 
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passage is the inciting factor in the pathogenesis of gallstone-induced pancreatitis. 
Microlithiasis refers to “aggregates <5 mm in diameter, of cholesterol mono 
hydrate crystals or calcium bilirubinate granules detected as “sludge” within the 
gallbladder” on ultrasonography or on examination of bile obtained during ERCP. 
An etiologic role for microlithiasis in acute pancreatitis remains unproved.   
However, cholecystectomy or endoscopic sphincterotomy can reduce the 
risk of recurrent acute pancreatitis in patients with microlithiasis. 
ALCOHOL 
Excessive ethanol consumption is the next commonest cause of acute 
pancreatitis worldwide. It is more is more prevalent in young men (30 to 45 years 
of age) than in women18.  However, only 5% to 10% of patients who drink alcohol 
develop acute pancreatitis.  Heavy ethanol abuse (>100 g/day for at least 5 years), 
smoking, and genetic predisposition, contribute to acute pancreatitis. As compared 
with non-smokers, the relative risk of alcohol-induced pancreatitis in smokers is 
4.919.The nature of alcohol consumed is less important than a daily consumption 
of between 100 and 150 g of ethanol. In a patient with a history consumption on 
alcohol, with absence of other causes of pancreatitis, the initial attack of acute 
pancreatitis is deemed to be due to alcohol. 
The “secretion with blockage” mechanism shows that ethanol 
consumption causes increased tone of sphincter of Oddi, and, it is a metabolic 
toxin to pancreatic acinar cells, where it can disrupt enzyme synthesis and 
secretion. Ethanol causes a brief secretary increase, followed by inhibition. This 
causes enzyme proteins to precipitate within the duct. Calcium then precipitate 
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within the protein matrix, resulting in multiple ductal obstructions. Ethanol also 
increases ductal permeability. 
SLUDGE 
Sludge within the gallbladder, is a suspension in the bile that may contain 
stones smaller than 3 mm diameter. Because small stones can be obscured by a 
sludge, the 2 are commonly referred to together as “biliary sludge and 
microlithiasis”.Components of this include of cholesterol monohydrate crystals or 
calcium bilirubinate granules Patients who harbour these are usually not 
symptomatic. On USG, this sludge causes a “mobile, low amplitude echo” which 
does not produce an acoustic shadow. It usually is visualised in the dependant part 
of the gallbladder 
TUMOURS 
Tumours, by possibly causing obstruction of the pancreatic duct, can cause 
in repeated episodes of acute pancreatitis, particularly in persons more than 40 
years of age. The commonest neoplasm which presents in this manner is 
intraductal papillary mucinous neoplasm (IPMN) 20. Acute pancreatitis may be the 
initial presentation in patients with adenocarcinoma of the pancreas. 
Metastases from other cancers (lung, breast) to the pancreas have also 
caused pancreatitis. Sometimes and adenoma from the papilla can also cause 
obstruction and subsequent acute attack of pancreatitis. 
MEDICATIONS 
Drugs though not a very common cause, form an important etiology of 
acute pancreatitis. Drug- induced pancreatitis probably account for <1 % of cases. 
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Drug-induced pancreatitis tends to occur within 4 to 8 weeks of beginning a drug. 
It usually does not manifest as an adverse drug reaction prior to onset of an attack 
of pancreatitis. 
 
 
 
 
 
 
 
 
 
 
 
There are many possible mechanisms of drug-induced pancreatitis. The 
most common mechanism is a “hypersensitivity reaction”. This usually occurs 
between the 4th and 8th week of starting on the medication, and does not depend 
on the dosage. On challenging the patient with the drug, recurrent attack results 
with an earlier onset, in a few days or even within a few hours of the dose. 
Aminosalicylates, metronidazole, and tetracycline group of drugs, act by this 
mechanism. 
The second mechanism is thought to be due to accumulation of a 
metabolite of the drug which is toxic, and typically presents after months. Sodium 
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valproate and didanosine (DDI) belong to this category. Drugs causing 
hypertriglyceridemia like thiazide diuretics, isotretinoin, tamoxifen also belong to 
this category.  
Few drugs are intrinsically toxic, and an excessive dosage of these can 
result in pancreatitis (erythromycin, acetaminophen). 
In general, drug-induced pancreatitis is mild and self limited. The diagnosis 
should only be entertained after alcohol, gallstones, hypertriglyceridemia, 
hypercalcemia, and tumors (in appropriate-aged patients) have been ruled out. 
METABOLIC DISORDERS 
HYPERTRIGLYCERIDEMIA 
Hypertriglyceridemia is probably the third most common cause of 
pancreatitis, accounting for 2% to 5% of cases. Serum triglyceride levels more 
than 1000 mg/dL can result in  attacks of acute pancreatitis. However, recent 
studies suggest that the serum TGs may have to be even higher to precipitate acute 
pancreatitis, perhaps above2000 mg/dL, and with obvious lactescent (milky) 
serum due to increased concentrations of chylomicrons19. The mechanism of 
hypertriglyceridemia causing acute pancreatitis is not clear, but the release of free 
fatty acids by lipase may damage pancreatic acinar cells or endothelial cells. The 
hydrolysis of TGs by pancreatic lipase and release of free fatty acids that induce 
free radical damage can directly injure cell membranes. Disorders of lipoprotein 
metabolism are conventionally divided into primary (genetic) and secondary 
causes, including diabetes mellitus, hypothyroidism, and obesity/metabolic 
syndrome. 
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HYPERCALCEMIA 
Hypercalcemia due to any cause is associated with acute pancreatitis very 
rarely. Proposed mechanisms include deposition of calcium salts in the pancreatic 
duct and calcium activation of trypsinogen within the pancreatic parenchyma21. 
Primary hyperparathyroidism causes less than 0.5% of all cases of acute 
pancreatitis. 
Hyperparathyroidism attributes to a minority of cases of acute pancreatitis. 
Pancreatitis can also be due to other causes of hypercalcemia, like metastatic bone 
disease, TPN, sarcoidosis, vitamin D toxicity, and infusion of calcium in high 
doses peri-operatively during cardiopulmonary bypass. 
INFECTIONS 
The diagnosis of acute pancreatitis caused by an infection requires 
evidence of acute pancreatitis, evidence of an active infection, and the absence of 
a more likely cause of acute pancreatitis. 
Acute pancreatitis has been implicated to be caused by viruses (mumps, 
coxsackievirus, hepatitis A, B, and C, and several herpesviruses, including 
cytomegalovirus, varicella-zoster, herpes simplex, and Epstein Barr virus), MMR 
vaccine, bacteria (Mycoplasma, Legionella, Leptospira, Salmonella, TB, and 
brucellosis); fungi (Aspergillus, Candida); and parasites (Toxoplasma, 
Cryptosporidia, Ascaris lumbricoides, Clonorchis sinensis). C. sinensis and A. 
lumbricoides cause pancreatitis by obstructing the duct of Wirsung. 
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VASCULAR DISEASES 
Ishacemia to the pancreas has been rarely associated with acute 
pancreatitis. In most cases, it is mild, however a severe  necrotizing pancreatitis 
can occur. Vasculitis like SLE and polyarteritis nodosa can cause vasculitis. 
Atheromatous embolization of cholesterol plaques after trans-abdominal 
angiography, intra-operative hypotension, hemorrhagic shock, ergotamine 
overdose, and trans catheter arterial  embolization for hepatocellular carcinoma. 
TRAUMA 
Both penetrating and blunt trauma can result in acute pancreatitis. Other 
intra-abdominal organs are also usually involved. Laparotomy is mandatory in all 
every case of penetrating injury for the assessment of injuries and to manage them 
accordingly. Blunt injury to the abdomen causes pancreatic injury by compression 
of pancreas against the spine 
IATROGENIC 
Iatrogenic pancreatitis is mainly due to ERCP, which can cause significant 
morbidity. Asymptomatic hyperamylasemia occurs after 35% to 70% of ERCPs22. 
Post-ERCP pancreatitis is believed to be multi-factorial, involving a combination 
of chemical, hydrostatic, enzymatic, mechanical, and thermal factors acute 
pancreatitis occurs in 5% of diagnostic ERCPs, 7% of therapeutic ERCPs, and up 
to 25% in those with suspected SOD or in those with a history of post-ERCP 
pancreatitis23. 
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POST-OPERATIVE STATE 
Pancreatitis can be secondary to surgeries of the alimentary tract or 
thoracic cavity. Pancreatitis occurs after 0.4% to 7.6% of cardiopulmonary bypass 
operations.27% of patients undergoing cardio vascular surgery develops hyper-
amylasemia, and 1% develops necrotizing pancreatitis. Pancreatitis can occur 
following liver transplantations. Postoperative pancreatitis is associated with 
higher morbidity as compared to other causes. 
SPHINCTER OF ODDI DYSFUNCTION 
Sphicter of Oddi dysfunction has an unclear associated with acute 
pancreatitis. The main argument in favour of this entity as a cause of acute 
pancreatitis is the many observational series that report that endoscopic pancreatic 
sphincterotomy or surgical sphincteroplasty reduces recurrent attacks of 
pancreatitis24. 
PANCREAS DIVISUM 
Pancreas divisum is the commonest congenital maldevelopment of pancreas, the 
vast majority of whom never develop pancreatitis.  
Obstruction of the minor papilla is thought to the causative factor in these cases. 
Genetic factor has a possible role to play in patients suffering from pancreatitis, 
who have pancreas divisum. 
MISCELLANEOUS 
Crohn’s disease has been associated with the development of acute pancreatitis. 
Celiac disease has an uncertain association. Hyper amylasemia in these patients 
have been thought to be due to disruption of small bowel mucosal barrier. 
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Pancreatitis has been seen in patients after severe burns. 
Smoking has been suggestive to be causative in acute pancreatitis. 
Acute pancreatitis resulting from autoimmune pancreatitis is rare, seen in 
type II disease, and is associated with granulocyte epithelial lesions. 
PATHOPHYSIOLOGY 
Acute pancreatitis occurs in varying degrees of severity, the determinants 
of which are multifactorial. The generally belief is that, pancreatitis begins with 
activation of digestive enzymes within the acinar cells, which results in acinar cell 
injury. The fact that zymogen and lysosome co-localization occurs before 
elevation of amylase level, pancreatic edema, and other markers of pancreatitis 
are evident, suggests that co-localization is an early step in the pathophysiology of 
pancreatitis. 
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CO-LOCALIZATION HYPOTHESIS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Co-Localization Hypothesis 
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The initiating factor in the pathogenesis of acute pancreatitis is activation 
of trypsinogen inside the acinar cells in large quantities. Trypsin, activates other 
proenzymes, such precursors of elastase, phospholipase A2 (PLA2), and 
carboxypeptidase, to active forms. It also activates the complement and kinin 
systems. Active enzymes auto-digest the pancreas, causing a vicious cycle 
releasing further active enzymes. Very early in the development of the disease 
(shortly after the onset, but before morphologic or biochemical changes are 
apparent), digestive enzymes are localized in cytoplasmic vacuoles that also 
contain the lysosomal hydrolase cathepsin B, which is known to activate 
trypsinogen. 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Activation of Enzymes 
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Small amounts of active trypsin which are normally produced within the 
pancreas, are usually inactivated by trypsin inhibitors. Because exocrine pancreas 
produces several enzymes that are potentially injurious to it, it prevents 
autodigestion by intracellularly assembling the inactive precursors of these 
enzymes, called proenzymes or zymogens, which are then transported and secreted 
outside of the gland. Their activation occurs safely in the duodenum, where the 
brush-border enzyme enteropeptidase (or enterokinase) activates the trypsinogen, 
and the resulting trypsin then activates the other zymogens in a cascade reaction. 
To further protect the pancreas from these potentially harmful digestive enzymes, 
they are segregated from the cytoplasmic space within acinar cells by being 
enclosed within membrane-bound organelles, referred to as zymogen granules. 
Another layer of protection is provided by the synthesis of trypsin inhibitors, 
which are transported and stored along with the digestive enzyme zymogens. 
These are available to inhibit small amounts of prematurely activated trypsinogen 
within pancreatic acinar cells. It is generally theorized that acute pancreatitis 
occurs when this process goes awry and the gland is injured by the erroneously 
activated enzymes that it produces. 
There are three reasons for this theory: 
a) The pancreas is digestible by the activated enzymes of the duodenum; 
b) Activated digestive enzymes are found within the pancreas during 
pancreatitis 
c) The histology of pancreatitis is suggestive of a coagulative necrosis 
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Intra-acinar pancreatic enzyme activation causes auto digestion of the 
normal pancreatic parenchyma. In response to this initial insult, acinar cells 
release pro-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α), 
interleukins (IL)-1, -2, and -6, and IL-1and 10, which are anti-inflammatory. 
Blockage of secretion of ezymes of the pancreas, with on-going secretion 
disrupts the acinar cell barrier. 
This results in exudation of enzymes from acinar cells, and ductal secretion 
into interstitial spaces. This may explain the rapid development of interstitial 
edema and the increase in the concentration of pancreatic enzymes in the serum24. 
The mechanism of gallstone induced pancreatitis is not clearly known. Bile reflux 
into the pancreatic duct, or ductal obstruction at the ampullary level due to stone 
or edema due to passing of stone have been proposed to cause pancreatitis. 
Stone impacted at the distal CBD mechanism of gallstone pancreatitis is 
that an impacted gallstone in the distal bile duct obstructs the pancreatic duct, 
causing increased pressure within it, thereby resulting in damage of acini and 
ductal epithelial cells. 
The patho-physiology of acute pancreatitis begins with injury of acinar 
cells, which may progress to cause local inflammatory complications, SIRS and 
sepsis. Mechanisms of injury are microcirculatory injury, leukocyte chemo-
attraction, release of pro and anti inflammatory cytokines, oxidative stress, 
extravasation of pancreatic enzymes, and translocation of bacteria into systemic 
circulation. 
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The release of pancreatic enzymes damages the vascular endothelium, the 
interstitium, and acinar cells26. Injury to acinar cells results in expression of 
endothelial cell adhesion molecules like VCAM, which further worsens the 
inflammatory response. 
These abnormalities increase vascular permeability and cause edema of the 
gland causing “interstitial pancreatitis”. 
Vascular injury can result in micro-circulatory failure and exacerbation of 
injury to the pancreas. 
Reperfusion of the pancreas which is already damaged can worsen the 
injury by release of free radicals and inflammatory mediators. Activation of the 
complement pathway and release of C5a play an important role recruiting of 
macrophages and leukocytes. These inflammatory cells will release pro-
inflammatory cytokines, like TNF, IL-1, IL-6, and IL-8, and platelet-activating 
factor (PAF) in response to transcription factors such as nuclear factor κB. 
Very early in the development of the disease (shortly after the onset, but 
before morphologic or biochemical changes are apparent), digestive enzymes are 
localized in cytoplasmic vacuoles that also contain the lysosomal hydrolase 
cathepsin B, which is known to activate trypsinogen 
Some cases of acute pancreatitis progress to develop systemic 
complications, fever, (ARDS), pleural effusion, renal shutdown, shock, 
myocardial depression, and metabolic complications.  
Systemic inflammatory response syndrome is frequently seen in acute 
pancreatitis, which is probably mediated by activated enzymes of the pancreas and 
40  
cytokines which are released into the portal circulation from the inflamed 
pancreas. 
Cytokines reach the liver and Kupffer cells, which, in turn, causes 
increased and secretion of cytokines into the systemic circulation. These cause 
acute phase protein synthesis (C-reactive protein [CRP], IL-6) and may cause 
SIRS and organ damage leading on to MODS and death. 
ARDS can be induced by active phospholipase-A, which cleaves lecithin, 
an important constituent of pulmonary surfactant. Acute renal failure may be the 
result of hypotension and decreased intra vascular volume. Depression of 
myocardium and shock may be due to release of vasoactive peptides and a 
myocardial-depressant factor. Metabolic complications will include 
hyperlipidemia, hypocalcemia, hyperglycemia with or without ketosis, and 
hypoglycemia. The cause of hypocalcemia is multiple, and includes 
hypoalbuminemia, hypomagnesemia, calcium-soap formation, hormonal 
imbalance. Combination of genetic mutations in CFTR, in the pancreatic duct may 
predispose patients with pancreas divisum, to develop acute pancreatitis. 
FACTORS DETERMINING SEVERITY OF THE DISEASE 
Severity of pancreas varies widely. Some patients may experience a mild 
form of disease which is self-limiting, while others suffer a severe form and 
sometimes a lethal attack. Factors which determine the severity of pancreatitisare 
multi-factorial, but identification of these is of considerable therapeutic 
importance, because manipulation of these factors may lower the morbidity and 
mortality associated with this disease. The ultimate severity of the disease 
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depends on the extent of the systemic inflammatory response, and several 
cytokines and chemokines and their receptors that play an important role in the 
activation and migration of these inflammatory cells to the affected site. 
The list of factors associated with pancreatitis and associated lung injury, 
include tumour necrosis factor alpha, monocyte chemotactic protein-1, Mob1, 
interleukin-1 (IL-1), platelet activating factor (PAF), substance P, adhesion 
molecules [intercellular adhesion molecule-1 (ICAM-1) and selectins], IL-6, IL-8, 
IL-10, C5a, the CCR1 receptor , granulocyte macrophage colony-stimulating 
factor, macrophage migration inhibitory factor, COX-2, prostaglandin E1, nitric 
oxide, and reactive oxygen species. 
CLINICAL FEATURES 
Diagnosing an acute pancreatitis by clinical history and examination is 
quite challenging, as it clinically mimics other causes of acute abdomen 
The diagnosis of acute pancreatitis is based on two or more of the following 
criteria:  
1) Severe abdominal pain 
2) Serum amylase or lipase more than three times higher than the institution’s 
upper limit 
3) Contrast enhanced computed tomography (CECT) findings of acute 
pancreatitis.  
4) Usually, if the first two criteria are present, and CECT is not required for 
diagnosis. 
42  
5) Other upper abdominal conditions that can be confused with acute 
pancreatitis will include perforated peptic ulcer, gangrenous small bowel 
obstruction, and acute cholecystitis. Because these pathologies often have a 
fatal outcome without surgery, urgent intervention is required in the small 
number of cases in which doubt persists. 
ABDOMINAL PAIN 
Abdominal pain is the usual presenting complaint in cases of acute 
pancreatitis. Biliary colic may persist and further develop into pancreatitis. Pain is 
usually felt diffusely over the abdomen. However, it may be only in the 
epigastrium, right hypochondrium, or, rarely, localised to the left upper quadrant 
of abdomen. Lower abdominal pain may be due to tracking of extravasation of 
pancreatic secretion to the left paracolic gutter. It has been described as "knifing" 
or "boring through" to the back, and can be relieved by the patient leaning 
forward. Onset of pain is rapid, reaching its maximum intensity within 10-20 
minutes. In some cases, pain is gradual in onset and progression, taking hours to 
reach its peak intensity. Pain is steady, moderate to very severe. Band-like 
radiation of the pain, to the back occurs in half the patients. Pain lasting for only a 
few hours suggests other intra abdominal pathology. Pain is absent in 5% to 10% 
of attacks, and a painless presentation may be a feature of serious fatal disease27. 
Pain often precedes onset of nausea and vomiting, with retching often 
persisting even after the stomach has emptied. 
Nausea and vomiting is present in 90% of individuals affected with acute 
pancreatitis. Patient also has associated retching, and pain does not subside on 
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vomiting. Vomiting is either because of intractable pain or secondary to 
inflammation of the posterior wall of stomach. 
PHYSICAL FINDINGS 
Examination findings depend on the severity of the attack. Patients with 
mild disease, may not appear sick. 
On examination, the patient may have tachycardia, tachypnea, hypotension, 
and hyperthermia. The temperature is usually mildly elevated in uncomplicated 
pancreatitis. 
Pulse rate is usually in the range of 100 to 150 /minute. Hyper or 
hypotension may be present secondary to third space fluid loss and decreased 
circulatory volume. 
The temperature may be normal, but within 1to 3 days it may increase to 101°F to 
103°F due to severe retro-peritoneal inflammation. 
Tachypnoes, with painful shallow breathing may be due to exudates below 
the diaphragm. Dyspnea may be due to pleural effusion, atelectasis, ARDS, or 
congestive cardiac failure. 
Tenderness may be mild without guarding in mild acute pancreatitis. In 
severe pancreatitis, patients may appear sick, and may present with distension of 
abdomen, more so in the epigastrium, secondary to ileus. 
Epigastric guarding may be present. Tenderness and guarding can be. 
Rigidity is not a common feature, and when present, other causes of diffuse 
peritonitis should be ruled out. Bowel sounds are either decreased or not heard. 
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Other findings in the abdomen, include ecchymosis over the flanks “Grey 
Turner’s sign” or in the peri-umbilical area “Cullen’s sign”, due to extravasion of 
secretions which are hemorrhagic.  
These findings are not often present and are poor prognostic factors. 
 
 
 
 
 
 
 
 
Figure 12: Gray Turner’s Sign 
Pleural effusion secondary to pancreatitis can cause a dull note on 
percussion, and decreased breath sounds on auscultation. 
Dullness to percussion and decreased breathing sounds in the left or, less 
commonly, in the right hemithorax suggest pleural effusion secondary to acute 
pancreatitis 
Patients may be disoriented and agitated or in coma, may hallucinate, 
which may be due to alcohol withdrawal, hypotension, electrolyte imbalances like 
hyponatremia, hypoxia, fever, or toxic effects of pancreatic enzymes on the 
central nervous system. 
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Uncommon findings in acute pancreatitis include panniculitis with 
subcutaneous nodular fat necrosis that may be accompanied by polyarthritis. 
Subcutaneous fat necroses are 0.5- to 2-cm tender red nodules that usually 
appear over the distal extremities but may occur over the scalp, trunk, or buttocks. 
They occasionally precede abdominal pain or occur without abdominal pain, but 
usually they appear during a clinical episode and disappear with clinical 
improvement. 
Some physical findings point to a specific cause of acute pancreatitis. 
Enlarged liver, spider angioma, and Dupuyten’s contracture point towards ethanol 
induced pancreatitis. Tendon xanthoma and lipemia-retinalis point towards 
hyperlipidemia as the cause of  pancreatitis. 
Band keratopathy is seen in hypercalcemic patients 
                                       DIAGNOSIS 
PANCREATIC ENZYMES 
In general, the diagnosis of acute pancreatitis relies on at least a 3-fold 
elevation of serum amylase or lipase in the blood27. 
SERUM AMYLASE 
Pancreatic diseases cause elevated pancreatic isozyme of amylase, and 
specifically measuring this isozyme improves the accuracy of diagnosis. But this 
is not routinely used. 
Total amylase is measured routinely since it cheaper and easier. It increases 
6 to 12 hours after the disease onset and is cleared from the blood rapidly with a 
half life of 10 hrs. 
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Renal clearance is less than 25 %. This enzymes raises from the first day of 
disease onset, persisting for about 3-5 days.  
Serum amylase is neither very sensitive nor specific. Sensitivity is about 
85%.It may be within normal limits or only mildly raised in severe pancreatitis, or 
in chronic pancreatitis due to very little remnant of acinar tissue. 
Hypertriglyceridemia induced pancreatitis may be associated with normal level of 
amylase. 
Upto 50% of patients with elevated amylase levels may infact have no 
evidence of pancreatic disease. Elevated amylase levels is suggestive, rather than 
diagnostic of pancreatitis. Hyper amylasemia may be present in asymptomatic 
patients. 
SERUM LIPASE 
The sensitivity of serum lipase for the diagnosis of acute pancreatitis is 
similar to that of serum amylase and is above 85%29. However, Lipase has higher 
specificity in diagnosing acute pancreatitis as it is not affected by other causes of 
hyper amylasemia. Serum lipase level is almost always raised on the first day of 
the disease, and it remains increased for longer, thus providing a higher 
sensitivity. Combining amylase and lipase does not improve diagnostic accuracy 
and increases cost. 
ROUTINE BLOOD INVESTIGATIONS 
The polymorphonucleocyte count is markedly elevated in severe disease, 
and is not related to a presence of infection. 
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The blood glucose also may be high and associated with high levels of 
serum glucagon. 
Liver enymes (AST, ALT and ALP) and bilirubin may also be elevated in 
pancreatitis induced by gallstones. 
It should be stressed that the decrease in serum calcium seen in patients 
with acute pancreatitis is mainly related to the decreased serum albumin. 
MCV shows some variation in ethanol and non-ethanol related causes of 
acute pancreatitis. Alcoholic patients tend to have higher MCV due to the toxic 
effects of alcohol on erythrocytosis in the marrow. 
TRYPSINOGEN AND TRYPSINOGEN ACTIVATED PEPTIDE 
Urinary  concentrations  of trypsinogen activated peptide, have been shown 
to correlate well with the severity of acute pancreatitis at admission, but its 
measurement by a manual enzyme immunoassay, combined with the limited 
stability of the TAP assay, restricts its usage as an emergency room test. 
Higher positive likelihood ratio for the urinary trypsinogen-2 test strip than 
for CRP at 24 hours after admission, was confirmed in a multicenter trial led by 
Glasgow Johnson et al 
TAP is cleaved from the amino-terminal end of trypsinogen when trypsin 
is activated. TAP is the most studied activation peptide in acute pancreatitis. 
Unfortunately, the TAP test kit is not commercially available, and therefore the 
TAP measurement is not a routine clinical measurement. 
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IMAGING 
PLAIN X- RAY 
Findings on a plain abdominal radiograph, can vary from no specific 
finding in mild disease to focal ileus of a segment of small bowel (“sentinel loop”) 
or the “colon cut-off sign in severe disease. 
 
 
 
 
 
 
 
 
Figure 13: Sentinel Loop, Colon cut-off sign 
 
Also, X-ray abdomen helps to exclude other acute abdominal pathologies, 
which may require immediate intervention. 
Appearance of hollow viscus depends on the location as well as spread of 
pancreatic exudates. Gastric abnormalities are due to exudate in the lesser sac, 
causing forward displacement of the stomach, with separation of contour of the 
stomach from transverse colon. Small bowel abnormalities are due to 
inflammation in near the small bowel mesentery, and include ileus of one or more 
loops of jejunum (the sentinel loop), of the distal ileum or cecum or the 
duodenum. Generalized ileus can occur in severe disease. 
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Spread of the exudate to specific areas of the colon, may produce spasm of 
that area of the colon with no air distal to the spasm (the colon cut-off sign), or 
dilated colon proximal to the spasm. 
ULTRASOUND ABDOMEN 
Abdominal ultrasound is useful in the initial 24 hours of admission, to 
identify gallstones, CBD dilatation due to choledocholithiasis, and ascites. 
Ascites is commonly seen in patients with moderate to severe pancreatitis, 
as protein rich fluid extravasates from the intravascular compartment to peritoneal 
cavity. Pancreas is uniformly enlarged and hypoechoic, and obscured by bowel 
gas. Ultrasound is used to serially monitor the size of pseudocyst. 
CECT ABDOMEN 
CECT is the most important mode of imaging in diagnosing acute 
pancreatitis as well as its intra abdominal complications. 
The 3 main indications for a CT in acute pancreatitis are  
1) To rule out other causes of acute abdomen 
2) To stage the severity the disease 
3) To identify complications of acute pancreatitis 
Helical CT is the most common imaging used. CT taken after oral followed by 
intravenous contrast helps in identifying necrosis of pancreas. 
If there is a normal perfusion of the pancreas, it could be due to interstitial 
pancreatitis and defects in perfusion is due to necrosis of pancreas. 
A CECT abdomen has to be performed in patients who do not improve after 
the first week of symptoms. 
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  Pancreatic necrosis, may not be apparent on CT upto 48-72 hours after the 
onset of the disease. 
The presence of air bubbles on CT denotes infected necrosis or pancreatic 
abscess. 
BALTHAZAR GRADING OF CT SEVERITY OF ACUTE 
PANCREATITIS 
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Early CT often fails to detect an evolving necrosis, which becomes well 
demarcated after about 48-72 hours after the onset of symptoms. CT is not very 
useful in diagnosing necrosis or in predicting the severity within 24 hours of onset 
of symptoms of illness.  
The sensitivity of identifying pancreatic necrosis using CECT scan 
approaches 100%, 96 hours diagnosis.  
CT scans also been useful as a diagnostic and therapeutic modality in 
infected pancreatic necrosis. Image guided aspiration of necrosis can be done, 
when the patient is not improving clinically or in patients who experience clinical 
decline. 
 
 
 
 
 
 
  
 
Figure 14: Necrosis on CT 
MRI 
MRI abdomen provides similar information CT, in identifying the severity 
of the disease.  MRI is as good as CT in identifying necrosis and fluid collections. 
MRI is better than CT, and equal to EUS and ERCP in detecting 
choledocholithiasis. The use of IV secretin, before MRCP helps in better 
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delineation of the pancreatic duct. This is particularly useful in the evaluation of 
patients with idiopathic and recurrent pancreatitis30. 
ENDOSCOPIC ULTRASOUND AND ERCP 
EUS is not very useful early in acute pancreatitis. EUS during an attack of 
acute pancreatitis and weeks following an episode, shows signals 
indistinguishable from chronic pancreatitis and malignancy. However, after a 
month, particularly in patients with idiopathic interstitial pancreatitis, EUS may be 
helpful in identifying the presence of small tumours, pancreas divisum, and CBD 
stones. EUS is equivalent to MRCP and ERCP but far more sensitive than either 
abdominal ultrasound or CT in detecting common duct stones31. ERCP appears to 
be safe in acute pancreatitis if needed, such as in the setting of biliary pancreatitis, 
with raising serum bilirubin and biliary sepsis. 
CLASSIFICATION OF SEVERITY 
Various classification systems have been devised in the past. 
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The most widely accepted classification system for severity in acute 
pancreatitis, the Atlanta classification, was reported in 1992. Atlanta 1992 
classification, divides acute pancreatitis into two groups: mild and severe.  
Severe disease is defined by the presence of organ failure, local pancreatic 
complications on imaging (acute fluid collection, pancreatic necrosis, pseudocyst 
and pancreatic abscess), and/or poor prognostic scores (Ranson's ≥3 and/or 
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APACHE-II≥8). Atlanta 1992 has offered a universally applicable classification 
system, that successfully served clinical studies and helped in the comparison of 
data from different centers for over 20 years. 
Due to limitations in the 1992 Atlanta classification of acute pancreatitis,  
and improved understanding of the pathogenesis of acute pancreatitis, the 1992 
classification has been updated.  
The revised of the Atlanta classification (Atlanta 2012) divides acute 
pancreatitis severity into three groups: mild, moderate, and severe. 
 
 
 
 
 
 
 
 
 
Mild acute pancreatitis which is characterized by absence of organ failure 
and local or systemic complications. 
Moderately severe acute pancreatitis which is characterized by transient 
organ failure (resolves within 48 hours) and/or local or systemic complications 
without persistent organ failure (> 48 hours) 
Severe acute pancreatitis which is characterized by persistent organ failure 
that may involve one or multiple organs 
55  
In the early phase, this is based on clinical parameters, whereas in the 
following weeks, this subdivision is based on a combination of clinical parameters 
and morphologic complications, either requiring an active intervention (surgical, 
endoscopic, radiologic) or other supportive measures (like need for vasopressors, 
ventilatory support, or renal dialysis). 
Necrotizing pancreatitis is defined as the “The presence of parenchymal necrosis 
and/or necrosis of peripancreatic fat.” 
The updated Atlanta classification, includes patients with peri-pancreatic 
necrosis only (that is, without necrosis of  pancreatic parenchyma) in the category 
of Necrotizing Pancreatitis. 
Edematous interstitial pancreatitis usually runs a mild  course, but a small 
subset of patients suffer a fulminant attack and die within 2 to 5 days; these 
patients  have severe disease, but do not meet criteria of necrotizing pancreatitis. 
EARLY AND LATE ORGAN FAILURE 
Acute pancreatitis runs a biphasic course. The first phase, is characterized 
by a systemic inflammatory response syndrome (SIRS) which lasts for about 2 
weeks. The second phase, is characterized by a counter-active anti-inflammatory 
response syndrome (CARS), which is characterized by a state of immune 
suppression. Organ failure in the SIRS phase is considered not to be due to 
infection, but rather due to severe systemic inflammation. Organ failure in the 
CARS phase, is related to secondary infections, like infected pancreatic necrosis. 
Infections do occur in the SIRS phase, but bacteremia and (ventilator-associated) 
pneumonia are common. Organ failure can affect any organ system, but the 
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pulmonary and the cardiovascular systems are predominantly affected. Organ 
failure in the SIRS phase, is diagnosed at a median of 2 days after admission, but 
can be present even at admission. Half the patients who die from acute 
pancreatitis, suffer from organ failure but not from infected pancreatic necrosis. 
3 typical scenarios in which organ failure presents, include the following: 
1) Early-onset organ failure (week 1), intensive care admission, followed by 
improvement with supportive care and intensive care treatment (weeks 2 
through 3). In the weeks to follow (weeks 3 through 5), clinical deterioration 
occurs. This sequence of events is highly indicative of infected necrosis. 
2) Without early organ failure, clinical stability is suddenly complicated by 
deterioration in 3rd to 4th week  of admission. Again, the chances of infected 
necrosis as the cause of clinical deterioration are high. 
3) Early-onset organ failure does not improve, even after 2 to 3 weeks of 
supportive therapy, in the intensive care unit. In this case, a fine-needle 
aspiration (FNA) of one of the collections is done to differentiate between 
persistent SIRS or infected necrosis and to determine the need for intervention. 
If, however, gas bubbles are seen on CECT scan, no further diagnostic 
procedure is required, and an intervention to treat the source of infection needs 
to be planned. 
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SCORING SYSTEMS 
1) RANSON’S SCORING SYSTEM  
The earliest scoring system designed to evaluate the severity of acute 
pancreatitis was introduced by Ranson and colleagues in 197432. It predicts the 
severity of the disease based on 11 parameters, which are obtained at the time of 
admission and or 48 hours later. The mortality rate of acute pancreatitis, directly 
correlates with the number of parameters positive. Severe pancreatitis is 
diagnosed, if three or more criteria are fulfilled. The original criteria was analyzed 
in patients who primarily suffered from alcoholic pancreatitis, which was 
modified 8 years later, for those patients with gallstone pancreatitis. Higher 
Ranson’s scores predicts a more severe disease. 
 
 
 
 
 
 
 
 
 
Mortality rate in mild pancreatitis (scores <2), is 2.5% and in severe 
pancreatitis (scores >3) it is 62%. 
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The incidence of local and complications of acute pancreatitis correlates with 
Ranson’s score. This criteria is still widely used in the United States and Europe. 
The Ranson criteria has several setbacks, which include  
1. The criteria is complicated 
2. There are two different lists based on the etiology 
3. It takes 48 hours to fully calculate the criteria 
4. Validation beyond 48 hours has not been studied 
5. Some of the parameters in the criteria are not widely used routinely 
The overall sensitivity of the Ranson criteria is only 40% to 88%, and the 
specificity is only 43% to 90%.  
The positive predictive value is approximately 50%, and the negative 
predictive value around 90%. 
2) IMRIE’S PROGNOSTIC CRITERIA: 
During initial 48 hours 
WBC count > 15000/mm3 
Blood sugar > 10 mmol/L 
Serum urea > 16 mmol/L (no response to IV fluids) 
Po2 level < 60 mm Hg 
Serum ca2+ level < 2 mmol/L 
Lactic dehydrogenase> 600 IU/L 
AST / ALT>200μm/l 
Serum albumin level < 32 g/L 
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Ranson’s and Imrie’s scores indicate the severity at the time of admission 
and are not intended for monitoring the clinical course33. 
3) MODIFIED GLASGOW CRITERIA: 
This one was useful in both alcoholic and biliary pancreatitis 27. 
The score ≥ 3 means severe disease requires ICU care. 
P - PaO2 <8kPa or < 60 mmhg 
A - Age more than 55 years old 
N - Neutrophilia with WBC count>15x109/L 
C - Ca2+<2mmol/L or < 8 mg/dl 
R - Renal function, Urea >16mmol/L or > 45 mg/dl 
E – Enzymes:- serum LDH >600 IU/L; AST>200 IU/L 
A - Albumin <3.2g/dL 
S - Sugar: >10mmol/L or >180 mg/dl 
4) AGA GUIDELINES 
1. The American Gastroenterological Association (AGA) has issued guidelines 
for assessing the severity of pancreatitis. 
A. Prediction of severe disease be performed using the APACHE II system 
(using a cutoff of ≥ 8) (calculator 1). 
B. Those with actual or predicted severe disease and those with other severe 
comorbid conditions should be considered for triage to an ICU or 
intermediate medical care unit. 
C. In patients with predicted severe disease (APACHE II score of ≥8) and 
those with evidence of organ failure during the initial 72 hours, rapid-
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bolus CT should be performed after 72 hours of illness to assess the 
degree of pancreatic necrosis. CT should be used selectively based upon 
clinical features in patients who do not meet these criteria. 
2. Laboratory tests can be used as an adjunct to clinical judgment and the 
APACHE II score. A serum CRP >150 mg/L at 48 hours is preferred. 
5) APACHE II SCORING 
It is abbreviated as Acute Physiology and Chronic Health Evaluation 
(APACHE II) score. 
It is probably the most widely studied scoring system in acute pancreatitis. 
It has good negative predictive value and modest positive predictive value, in 
predicting severity of acute pancreatitis and can be performed daily. Decreasing 
values during the first 48 hours will suggest a mild attack, whereas increasing 
values suggest a severe attack. Studies suggest that mortality is less than 4% with 
a score < 8 and is 11 to 18% with a score > 8. 
APACHE II provides a general measure of the severity of disease, based 
on the patient’s age, previous health status, and 12 routine physiologic 
measurements. An APACHE II score of 8 or more, defines severe pancreatitis. It 
has the advantage of be used on a daily basis and has similar positive and negative 
predictive values as the Ranson score at 48 hours after admission. 
The major advantage of the APACHE II scoring system, when compared to 
the other systems, is that,  it can be used in monitoring patient’s response to 
therapy. However, Ranson and the Glasgow scales are mainly meant to assess the 
severity at presentation 
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The APACHE-II system assigns points for 12 physiologic variables, for 
age, and for chronic health status, in generating a total point score. 
The 12 variables are  
1. Temperature 
2. Heart rate 
3. Respiratory rate 
4. Mean arterial blood pressure 
5. Oxygenation 
6. Arterial pH 
7. Serum potassium, 
8. Serum sodium 
9. Serum creatinine 
10. Hematocrit;  
11. WBC count 
12. Glasgow Coma Scale 
Because age and severe chronic health problems reflect a diminished 
physiological reserve, they have been directly incorporated into APACHE II. 
The laboratory tests which are required are simple, routine and readily 
available.  
APACHE-II scores on admission and within 48 hours help distinguish mild 
from severe pancreatitis and to predict death. Most patients survive if APACHE-II 
scores are 9 or less during the first 48 hours. Patients with APACHE-II scores of 
13 or more have a high likelihood of dying. 
62  
It takes into account all the major risk factors that influence the outcome 
from the disease including the acute physiological derangements, as well as the 
patient’s ability to recover which may be diminished by advancing age or chronic 
disease. 
The range of the APACHE II score is wide, providing a better spread 
between the mild and severe attacks because varying weights are assigned to 
increasingly abnormal values, rather than all or no judgements. 
At admission, sensitivity is 34% to 70%, and specificity is 76% to 98%. 
At 48 hours, sensitivity remains less than 50%, but specificity is close to 90% to a 
Score of ≥ 2 indicates presence of organ failure. These scores were 
calculated within 72 hours of hospitalisation. The organ failure was 
classified as34: 
Transient (less than 48 hrs.) 
Persistent (more than 48 hrs.) 
 
6) BISAP (The Bedside Index for Severity in Acute Pancreatitis): 
This new scoring system has been developed recently for early detection of 
patients with risk of in hospital mortality. 
The BISAP score has been developed and validated retrospectively on a 
large population based study, done by Cardinal Health Clinical Outcomes 
Research Database, Marlborough, USA35. 
This score was published recently for clinical and research purpose, for its  
accuracy and reliability in patient stratification. 
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The BISAP includes38: 
1. Blood urea nitrogen (BUN) >25 mg / dl. 
2. Impaired mental status (GCS < 15). 
3. SIRS. 
4. Age >60 years. 
5. Pleural effusion 
SIRS was defined by presence of two or more of the following criteria: 
1. Pulse rate > 90/min. 
2. Respiratory rate > 20/min or PaCO 2 < 32 mm Hg. 
3. Temperature >100.4 F or < 96.8 F / < 36 or > 38 ° C. 
4. WBC count >12,000 or < 4,000 cells/mm3, or presence of more than 
 10% immature blasts. 
(SIRS - Systemic Inflammatory Response Syndrome) 
One point will be given for each variable present for a total of 5, score 
ranges from 0 to 5. 
The presence of a pleural effusion was determined by a CT scan, chest X 
ray or abdominal ultrasound obtained within 24 h of presentation. Imaging 
obtained within 24 h of presentation at the hospital of origin for transferred 
patients was also collected and reviewed. 
A BISAP score of three or more has been found to have high mortality and 
have predicted the necrosis and organ failure very well39. 
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ADVANTAGES: 
Simple and easy to calculate, usually done at the time of admission or within 
24 hrs of hospitalization. 
The scores prediction ability was tested across 390 hospitals among large 
number (36,248) of populations, in contrast to other studies which were based on 
small number patients. 
COMMONLY USED PREDICTIVE LABORATORY SCORING SYSTEMS 
AND THEIR CUTOFF FOR PREDICTED SEVERE PANCREATITIS 
 
 
 
 
 
 
 
MANAGEMENT OF ACUTE PANCREATITIS 
GENERAL CONSIDERATIONS 
Patients with acute pancreatitis need early and aggressive IV hydration to 
maintain hemodynamic stability and to adequately perfuse the kidneys and 
pancreas.  
These patients need adequate analgesia to eliminate or significantly reduce 
the pain. The patient is usually kept nil per oral until any nausea and vomiting 
have subsided. Abdominal pain can be treated with opiate analgesics, often by a 
patient-controlled- anesthesia pump. Opiate dosage is monitored carefully and 
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adjusted on according to on-going needs. Although morphine has been studied to 
increase the tone of sphincter of Oddi, and serum amylase, its use in treating the 
pain in acute pancreatitis has not been shown to affect outcome adversely33. 
Nasogastric intubation is not routinely used, because it has not been shown 
to be beneficial in mild pancreatitis. It is only used to treat gastric ileus or 
intractable nausea and vomiting. Similarly, routine use of proton pump inhibitors 
or H2 receptor blockers have not been shown to be very beneficial. 
The patient should be monitored carefully for signs of early organ failure 
like hypotension, pulmonary failure, or renal failure by closely monitoring vital 
signs and urinary output. Tachypnea should not be assumed to be due to 
abdominal pain. Monitoring oxygen saturation and, if needed, arterial blood gas 
measurement is advised, and also oxygen supplementation is mandatory in case of 
hypoxemia. Patients who exhibit signs of early organ dysfunction should be 
transferred immediately to an ICU, as clinical deterioration can be rapid and fatal. 
FLUID RESUSCITATION 
Recommendations regarding aggressive volume replacement are based on 
expert opinion, laboratory experiments, and retrospective as well as prospective 
clinical trials36-39. As the inflammatory process progresses early in the course of 
acute pancreatitis, there is extravasation of protein rich intravascular fluid, into the 
general peritoneal cavity as well as retroperitoneum, resulting in hemo 
concentration and reduced renal perfusion with associated elevation of blood urea 
nitrogen. Subsequently,  the reduced perfusion pressure into the pancreas results 
in microcirculatory changes which cause pancreatic necrosis. Hence, an admission 
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hematocrit greater than 44% and a failure of initial hematocrit to decrease at 24 
hours, have been shown to be predictors of necrotizing pancreatitis.  
An elevated or rising blood urea nitrogen is associated with increased 
mortality. Early vigorous IV fluid repletion to restore intravascular volume 
replacement is of foremost importance. The goal is to provide adequate 
intravascular volume to reduce the hematocrit and blood urea nitrogen, thus 
increasing pancreatic perfusion. 
Ringer lactate may be the preferred solution for initial hydration. Due to its 
bicarbonate content and stable pH, this isotonic solution, may prevent the 
development of metabolic acidosis. 
It is important to recognize that aggressive early volume repletion, will 
require caution in certain groups of patients (such as elderly patients or those with 
a history of cardiac and/or renal disease) to avoid complications, like volume 
overload, pulmonary edema, and abdominal compartment syndrome. 
RESPIRATORY CARE 
Hypoxemia (oxygen saturation <90%) requires oxygen supplementation, 
ideally by nasal prongs or by face mask if required. If nasal oxygen fails to correct 
hypoxia, or if there is respiratory fatigue and borderline respiratory reserve, early 
endotracheal intubation and assisted ventilation are required. It is important to use 
a Swan-Ganz catheter to identify if hypoxemia is due to congestive heart failure 
or due to primary pulmonary damage. 
Acute respiratory distress syndrome (ARDS), is the most serious 
respiratory complication of acute pancreatitis. ARDS is associated with severe 
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dyspnea, progressive hypoxia, and results in increased mortality. It usually occurs 
between the second and seventh day of onset of disease (but can be present at 
admission) and consists of increased pulmonary alveolar capillary permeability 
resulting in interstitial edema. Treatment for this condition is endotracheal 
intubation with positive end-expiratory pressure ventilation, with low tidal 
volumes to protect the lungs from volu-trauma. 
ANTIBIOTICS 
Antibiotics are not routinely indicated in mild acute pancreatitis. However, 
antibiotics would be appropriate in pancreatic sepsis (e.g., infected necrosis and, 
less often, abscess) and non pancreatic sepsis (e.g., line sepsis, urosepsis, or 
pneumonia). 
A recent updated metaanalysis clearly demonstrated no beneficial effect in 
the routine use of systemic antibiotic prophylaxis40. 
NUTRITION 
In severe acute pancreatitis, especially with pancreatic necrosis, 4 to 6 
weeks of artificial nutritional support may be necessary. Formerly, TPN was the 
standard method of refeeding patients with severe acute pancreatitis. Enteral 
nutrition is cheaper as well as safer, and is preferred. Enteral nutrition is 
hypothesized to decrease small bowel bacterial overgrowth, and to improve 
intestinal mucosal barrier function, thus reducing bacterial translocation and 
resultant infectious complications. The optimal route for the administration of 
enteral feeding, either through a nasojejunal or a nasogastric tube is yet to be 
established. 
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ENDOSCOPY 
The question of early removal of a possibly impacted gallstone in 
improving the outcome of gallstone pancreatitis remains a controversial issue. 
SURGICAL THERAPY 
Cholecystectomy is routinely performed in patients with gallstone 
pancreatitis, and a consensus conference suggested that in mild or severe gallstone 
pancreatitis, cholecystectomy should be performed as soon as the patient has 
recovered and the acute inflammatory process has subsided41. 
A second potential role for surgery in pancreatitis is to debride pancreatic 
necrosis (necrosectomy) or drain a pancreatic abscess. 
Sterile necrosis from infected necrosis by FNA of the pancreas. Sterile 
necrosis can be managed non-operatively because the mortality of this condition 
without surgery is less than 5%. However, surgical therapy of infected pancreatic 
necrosis carries a substantial mortality of 15% to 73 
The types of necrosectomy operations that have been recommended 
include necrosectomy with closed continuous irrigation via indwelling catheters, 
necrosectomy with closed drainage without irrigation, or necrosectomy and open 
packing. 
BILIARY PANCREATITIS 
Gallstones are the commonest cause of acute pancreatitis all over the globe. 
Most patients will pass off the offending stone during early hours of acute 
pancreatitis, but they have additional stones which are capable of inducing 
episodes. The issue of when to intervene is controversial. General consensus 
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favours either urgent intervention (cholecystectomy) within the first 48 to 72 
hours of admission, or a delayed intervention after 72 hours, during the same 
admission. Cholecystectomy and operative common duct clearance is possibly the 
best treatment for an otherwise healthy patient with obstructive pancreatitis. 
However, patients who are at a high risk for surgical intervention are treated by 
endoscopic sphincterotomy, with clearance of stones by ERCP 
In case of acute biliary pancreatitis, in which obstruction persists after 24 
hours of observation, emergency endoscopic sphincterotomy and stone extraction 
is indicated. Routine ERCP for examination of the bile duct is not encouraged in 
cases of biliary pancreatitis, as the possibility of finding residual stones is low, 
and also the risk of ERCP-induced pancreatitis is high. Patients who are suspected 
of harboring an impacted stone in the distal common bile duct or ampulla should 
have a confirmation by radiologic imaging (CT, magnetic resonance cholangio 
pancreatography, or endoscopic ultrasonography) before intervention is planned. 
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COMPLICATIONS 
Complications are divided into local and systemic 
LOCAL  
 Fluid collections 
 Pancreatic ascites/pleural effusion 
 Pancreatic pseudocyst 
 Pancreatic necrosis 
 Infected pancreatic abscess 
 Hemorrhage/pseudo aneurysm 
SYSTEMIC 
A. PULMONARY 
 
1. Pneumonitis, basal atelectasis 
2. ARDS 
3. Pleural effusion (L) 
 
B. CARDIOVASCULAR 
 
1. Hypotension 
2. Hypovolemia 
3. Sudden arrest &death 
4. Nonspecific ECG (ST-T wave) changes 
5. Pericardial effusion 
 
C. HEMATOLOGIC 
 
1. Hemoconcentration 
2. Disseminated intravascular coagulopathy 
D. GI hemorrhage 
1. Acid peptic disease 
2. Gastric erosion 
3. Portal/splenic vein thrombosis with variceal bleed 
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E. RENAL 
 
1. Oliguria 
2. Azotemia 
3. Renal vessel thrombosis 
 
F. METABOLIC 
 
1. Hyperglycemic state 
2. Hypocalcemic state 
3. Hyperlipidemia (triglyceridemia) 
4. Metabolic encephalopathy 
5. Sudden loss of vision (Purtscher's retinopathy) 
 
G. CENTRAL NERVOUS SYSTEM 
 
1. Acute psychosis 
2. Fat embolism occlusion 
3. Alcohol withdrawal syndrome (AWS) 
H. FAT NECROSIS 
 
1. Intra-abdominal saponification 
2. Subcutaneous tissue necrosis 
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MATERIALS AND METHODS 
Study design: Prospective study 
Setting: Department of General Surgery, Govt. Royapettah Hospital, 
Chennai. The study was conducted after obtaining the Institutional Ethical 
Committee approval. 
INCLUSION CRITERIA 
 
Acute pancreatitis is defined as 2 or more of the following 
- Characteristic abdominal pain. 
- Increased levels of Serum amylase and/or lipase 3 times the normal value. 
- Ultrasonography of the abdomen demonstrating changes consistent with 
acute pancreatitis. 
 
Individual components of the BISAP scoring system 
• BUN > 25 mg/dl 
• Impaired mental status (Glasgow Coma Scale Score < 15) 
• S IRS-SIRS is defined as two or more of the following: 
(1) Temperature of < 36 or > 38 ° C 
(2) Respiratory rate > 20 breaths/min or PaCO2 < 32 mm Hg 
(3) Pulse > 90 beats/min 
(4) WBC < 4,000 or >12,000 cells/mm3 or >10% immature bands 
• Age > 60 years 
• Pleural effusion detected on imaging 
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BISAP, bedside index for severity in acute pancreatitis; SIRS, systemic 
inflammatory response syndrome. 
One point is assigned for each variable within 24 hrs of presentation. 
A CT or MRI or USG of the abdomen, obtained at any time in the first 7 
days of hospitalization, is required to differentiate necrotizing from interstitial 
pancreatitis 
Organ failure is defined as a score of ≥ 2 in one or more of the three 
(respiratory, renal, and cardiovascular) out of the five organ systems initially 
described in the Marshall score42. 
Organ failure scores were calculated for all patients during the first 72 hrs 
of hospitalization based on the most extreme laboratory value or clinical 
measurement during each 24hrs period.  
Duration of organ failure was defined as transient (≤ 48 hrs) or persistent 
(>48 hrs) from the time of presentation. 
SYSTEM SCORE 
 0 1 2 3 4 
Respiration 
(PaO2/FiO2) 
>400 301-400 201-300 101-200 <100 
Renal (Creatinine 
mg/dl) 
<1.5 1.5-1.9 1.9-3.5 
 
3.5-5 >5 
CVS (Systolic 
BP) 
>90 <90, fluid 
responsive 
<90 fluid 
unresponsive 
<90 
pH<7.3 
<90 pH 
<7.2 
 
For non-ventilated patients, FiO2 can be calculated by : 
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Supplemental Oxygen (l/min) FiO2 
Room air 21% 
2 - 3 25% 
4 - 5 30% 
6 - 8 40% 
9 - 10 50% 
 
 
EXCLUSION CRITERIA 
 
• Proven cases of chronic pancreatitis. 
• Hereditary pancreatitis. 
• Acute  pancreatitis patients with organ failure at or within 24hrs of 
presentation 
Period of Study : November 2014 – June 2015 
Type of Study : Prospective study 
METHODS 
First 50 patients attending the general surgery department with 
clinical features of Acute Pancreatitis are evaluated clinically and subjected 
to laboratory and radiological investigations as per the designed proforma. 
Data pertinent to the scoring systems will be recorded within 24 h of 
admission to the hospital. 
Once diagnosis is established the patient disease severity will be 
assessed by BISAP scoring system 
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Sample Size : 50 Patients 
Source of Study: Patients diagnosed as acute pancreatitis in department of 
General Surgery, Government Royapettah Hospital. 50 of them are to be selected 
on the basis of non probability (purposive) sampling method 
• 50 patients attending the General Surgery Department with clinical 
features of Acute Pancreatitis are evaluated clinically and subjected to 
laboratory and radiological investigations as per the designed proforma. 
Data pertinent to the scoring systems will be recorded within 24 h of 
admission to the hospital. 
• Once diagnosis is established the patient disease severity will be assessed 
by BISAP Scoring system 
 
Statistical Analysis: Appropriate statistical tools. 
For each of 50 patients included in the study, BISAP scores were 
calculated by the Cardinal Health Data base system for BISAP scoring. 
Patients were classified to have mild or severe acute pancreatitis 
according to the definitions set by the Atlanta Classification guidelines 
(1992)44: 
Severe attack--Criteria for severity included: 
1) presence of one or more local complications: 
• Pancreatic necrosis 
• Pancreatic abscess 
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• Pancreatic pseudocyst 
2) Presence of one or more organ failures: 
• Shock (systolic BP< 90 mmHg). 
• Pulmonary insufficiency (PaO2< 60 mm Hg on room air). 
• Renal failure (Sr. creatinine > 2mg/dl after fluid replacement). 
• Gastrointestinal bleeding (> 500 ml estimated loss of blood within24 
hrs.). 
• DIC (thrombocytopenia and hypo fibrinogenemia and fibrin split 
products). 
• Severe hypocalcemia (<8mg/dl). 
Survivors were defined as patients discharged alive from the hospital 
and non-survivors were those who died from pancreatitis or its 
complications during hospitalization. 
Biliary Pancreatitis was presence of gall stones/biliary sludge in the 
gall bladder or bile duct, which was documented by any radiological 
methods. Alcoholic Pancreatitis was considered, when the patient found to 
have regular high intake of alcohol daily, or if there was binge of alcohol 
consumption prior to the onset of illness and has no signs of other 
etiologies present. Idiopathic pancreatitis was the one with no identifiable 
etiological factor based on the history, or after initial investigations. 
Patients were observed prospectively until discharge or death. 
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OBSERVATION AND RESULTS 
 
This study was conducted in the department of general surgery, 
Government Royapettah Hospital, Chennai for a period of 8 months. The 
50 persons with features of acute pancreatitis who fulfilled the inclusion 
criteria were enrolled in this study after obtaining an informed consent. 
Table 1: Age Distribution 
Age Range(years) No. of patients Percentage (%) 
21yrs -30yrs 9 18 
31yrs -40yrs 17 34 
41yrs -50yrs 15 30 
51yrs -60yrs 9 18 
Total 50 100% 
 
The    peak    incidence    of    the    disease    was    noted    in    the   4th 
decade of life 
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Table: 2 Gender Distribution 
 
Sex No. of patients Percentage (%) 
Male 45 90 
Female 5 10 
Total 50 100 
 
Out of 50 patients enrolled in this study there were 45 male and5 
female patients. 
Male: Female ratio-9:1 
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Table 3: Age Wise Sex Distribution 
 
Age Group 
(years) 
Sex 
 Male Female Total 
 N % N % N % 
21-30 7 15.6 2 40 9 18.0 
31 -40 16 35.6 1 20 17 34.0 
41 -50 15 33.4 0 0 15 30.0 
51 -60 7 15.6 2 40 9 18.0 
Total 45 100.0 5 100.0 50 100.0 
 
Mean age group of males: 41.13 years 
Mean age group of females: 39 years 
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Table: 4 Length of Hospital Stay 
 
Days in hospital No. of patients Percentage (%) 
1 day – 7 days 10 20 
8 days – 14 days 17 34 
15 days – 21 days 17 34 
22 days – 28 days 4 8 
> 28 days 2 4 
Total 50 100 
 
 
The length of hospital stay ranges from 1 day to 32 days. The mean 
length of hospital stay was 13.98 days. 
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Table 5 Clinical Features 
 
 
Symptoms No. of patients Percentage (%) 
Pain abdomen 48 96 
Fever 15 30 
Vomiting 22 44 
Jaundice 4 8 
Abdominal distension 7 14 
 
On clinical presentation, 96% of patients were presented with 
abdominal pain as chief complain. Rest of 4% who didn’t have abdominal 
pain had vomiting and fever as presenting symptoms. 
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Table: 6 Etiology 
 
Etiology No. of patients Percentage (%) 
Alcohol 27 54 
Gall Stone Disease 12 24 
Drug induced 1 2 
Hypertriglyceridemia 1 2 
Trauma 2 4 
Idiopathic 7 14 
 
History of consumption of alcohol and the possibility of it being the 
etiological factor were found in 27 patients. Gall stone disease was 
attributed in 12 patients. Hyperlipidemia and drugs as causative factor 
presented in 1 & 1 patients, respectively. There was clear cut history of 
blunt trauma with CT scan showed isolated pancreatic laceration presented 
in 2 cases. No cause could be attributed in rest of the 7 patients. 
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                  SENSITIVITY AND SPECIFICTY OF BISAP SCORING 
 
Table: 7 Outcomes 
 
 
Number of 
Patients 
Organ Failure 
Pancreatic 
Necrosis 
Mortality 
BISAP     
< 3 41 1 1 0 
> 3 9 5 4 2 
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Table 8: Necrosis 
 
 NECROSIS TOTAL 
 Yes No  
BISAP 
Score 
> 3 4 5 9 
< 3 1 40 41 
Total  5 45 50 
 
 
 
 
 
 
 
 
 
 
Parameter Estimate 
Sensitivity 80.00% 
Specificity 88.89% 
Positive Predictive Value 44.44% 
Negative Predictive Value 97.56% 
Diagnostic Accuracy 88.00% 
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Out of 50 patients, 41 patients presented with mild acute pancreatitis and 9 
patients presented with severe acute pancreatitis. Out of the 9 patients who 
presented with severe attack, 2 patients expired. 
In mild group the BISAP score ranges from 0 to 2 
In severe attack group the BISAP score ranges from 3 to 5 
The severity of acute pancreatitis was assessed by correlating the scoring 
systems with outcome in terms of organ failure, pancreatic necrosis and 
mortality, based on revised Atlanta classification system of acute severe 
pancreatitis. 
 Out of 41 patients presented with BISAP score <3, organ failure, pancreatic 
necrosis were presented in1&1patients respectively. There was no mortality in this 
group. 
Of the 9 patients presented with score >2, 5 patient developed organ 
failure and 4 patient developed pancreatic necrosis. There were 2mortalities in 
this group. 
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Table 9: Correlation with Organ Failure 
 
 Organ Failure TOTAL 
 Yes No  
BISAP 
Score 
> 3 5 4 9 
< 3 1 40 41 
Total  6 44 50 
 
 
 Estimate 
Sensitivity 83.33% 
Specificity 90.90% 
Positive Predictive Value 55.56% 
Negative Predictive Value 97.56% 
Diagnostic Accuracy 90.00% 
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Table 10: Correlation with Mortality 
 
 Mortality TOTAL 
 Yes No  
BISAP 
Score 
> 4 2 2 4 
< 4 0 46 46 
Total  2 48 50 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parameter Estimate 
Sensitivity 100.00% 
Specificity 95.83% 
Positive Predictive Value 50.00% 
Negative Predictive Value 100.00% 
Diagnostic Accuracy 96.00% 
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DISCUSSION 
 
Acute pancreatitis is a relatively common disease with varied clinical 
presentations. Severe acute pancreatitis has a high morbidity and mortality rate. 
Early hospitalization and management according to disease severity maybe 
beneficial to identify those who require aggressive interventions to prevent the 
severe attack. 
In this study, a relatively simple and bedside scoring system, 
BISAP is studied to assess the severity in patients with acute pancreatitis. 
An attempt also made to compare this study with previous similar studies 
done by others. 
Acute pancreatitis was found to be 9 fold more common in males 
than females in this study. However this result did not exactly match with 
previous study results, Vikesh K. Singhet et al44 (6:1), Papachristou et al1 
(5.1:1). This could be explained by alcohol ingestion being the commonest 
etiology in this study. 
In this study, the mean age was 40.06 years which matches with the 
study of Sarath et al (40.8 yrs), and is comparable to the study done by 
Vikesh K. Singh et al44 (49.6yrs), Papachristou et al  (51.7yrs). 
The mean age of non-survivors in this study was found to be 52 
years as compared to survivors being 41.23 years. Taking 52yrs of age as 
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cut-off value, increasing age was found to be correlated well with 
increasing incidence of mortality. Thus age is considered as a significant 
contributory factor in predicting the outcome of severe acute pancreatitis. 
The most common etiological factor in this study was alcohol 
(54%)& matches with Bidarkundi et al45(46.67%), but didn’t correlate 
with results of Vikesh K. Singh et al44 (21.4%), Papachristou et al (14%) in 
which gallstone disease found to be the most common cause, 27% & 36% 
respectively. 
The mean length of hospital stay was13.8 days in this study. In this 
study, increasing BISAP score was correlated well with the duration of 
hospital stay. 
The most common presentation was predominantly abdominal pain 
(96%), followed by vomiting (44%), vomiting (30%) & other 
manifestations. 
In this study, 41 patients were diagnosed to have mild acute 
pancreatitis and 9 patients found to have severe acute pancreatitis. All the 
9 were correctly predicted by BISAP Score. The severity was assessed by 
correlating the scores with three factors: organ failure, necrosis and 
mortality. 
Set cut off of BISAP score ≥3 was used to assess disease severity, 
based on previous studies done in this regard.  
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1) Papachristou et al1 where AUC (0.81, 0.78) significant 
correlation with prediction of the occurrence of organ failure (p 
<0.01), 2) Vikesh K. Singh et al44  and B U Wu etal46. 
In this study, 5/9 with BISAP > 3 developed pancreatic necrosis.  
Sensitivity and specificity of predicting organ failure, in this study with a 
BISAP score of  ≥ 3  was found to be  83.33% and  90.90% respectively, with a 
positive and negative predictive value of  55.56% and 97.56% respectively. 
Diagnostic accuracy of this study was found to be 90%. 
Sensitivity and specificity of predicting necrosis failure, in this study 
with a BISAP score of  ≥ 3  was found to be  80.00% and  88.89% 
respectively, with a positive and negative predictive value of  44.44% and 97.56% 
respectively. Diagnostic accuracy of this study was found to be 88%. 
BISAP ≥ 3 has significant correlation with prediction of pancreatic 
necrosis (p<0.01); (by Vikesh K. Singh et al) 
In this study, 4% underwent surgical intervention which comparable 
with Sarath etal. 
In this study, there was mortality in 2 patients. Both predicted by a 
score of >4. Cause of death in both patient was found to be MODS. The 
analysis for prediction of  mortality showed a sensitivity  of 100.00% and 
specificity of 95.83% respectively. Positive and negative predictive values 
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in the study were found to be 50 and 100% respectively. Diagnostic 
accuracy of this study was found to be 96 %, for a BISAP score of >4. 
 
 
This matches well with BUWuetal46, Papachristouetal, where 
specificity 87.6% PPV 15.4%, NPV 98.1%for BISAP and respectively.  
BISAP ≥ 4 was found to be significantly associated (p<0.04) with high 
mortality 
It was found to have high specificity, PPV and NPV for  mortality. 
This again matches well with previous study by Vikesh K. Singh et al44 and 
Papachristou et al1. 
In this study, 35.7% developed acute renal failure, 21.4% developed 
MODS, 14.2% developed septicemia and 7.1% developed other 
complications like ARDS, UGI bleed, etc. These complications were more 
likely seen in patients with BISAP ≥ 3, hence concluded that these are the 
patients in high risk group, who requires intensive monitoring and probably 
early intervention if necessary. 
BISAP score was found to have more sensitivity, specificity, positive 
and negative value, and diagnostic accuracy in predicting the severity of 
acute pancreatitis. Hence, BISAP score found to predict more number of 
patients, likelihood of progressing to severe disease. Larven et al stated in 
their study that, a prognostic scoring as say should preferably have high 
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positive and negative predictive values or high negative predictive value to 
assess the severity of acute pancreatitis. Hence, BISAP is considered a 
simple and  good bedside scoring system in predicting severity in acute 
pancreatitis. 
LIMITATIONS OF THIS STUDY 
 
 Small number of patients in this study. 
 
 The etiology in this study were found to be different from world 
wide accepted one, hence might not be correct to compare with other 
studies. 
 
 The GCS score used to assess the mental status of the patient got 
admitted were subject to inter observer variation. 
 
 Recently, it has been suggested that severe acute pancreatitis may 
have variable disease progression; therefore the lack of predictability 
might be associated with this disease variability. 
 
 Variation in timing of presentation of patients to the hospital after 
onset of symptoms may interfere with assessment of the scoring 
systems. 
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CONCLUSION AND SUMMARY 
 
 From this study, Alcohol (54 %) was found to be the most common 
etiological factor for acute pancreatitis. 
 Males were most commonly affected than female with a ratio of 
9:1. 
 
 The most common age groups of patients affected were in 4th 
decade of life. 
 
 The overall mortality in patients with severe acute pancreatitis was 
4%. 
 
 The BISAP score predicted disease severity and mortality 
significantly in this study 
 
From this study, we conclude that the BISAP score can be a simple, 
bedside and accurate clinical scoring system for the evaluation of disease      
severity in acute pancreatitis. Hence early identification and initiation of 
treatment can significantly alter the outcome 
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PROFOMA 
 
NAME:                                    DATE OF ADMISSION: 
 
AGE    :                                    DATE OF DISCHARGE: 
                                                  
SEX     :                                    ADDRESS: 
IP NO. 
OCCUPATION: 
CHIEF COMPLAINTS: 
HISTORY OF ALCOHOL INTAKE 
HISTORY OF DRUG INTAKE 
PAST HISTORY : 
GENERAL EXAMINATION: 
PULSE: 
BP: 
RESPIRATORY RATE: 
EXAMINATION OF ABDOMEN 
INVESTIGATIONS: 
CBC : 
TC: 
DC: 
 
RANDOM BLOOD SUGAR 
BLOOD UREA: 
SERUM CREATININE: 
SERUM AMYLASE : 
SERUM LIPASE : 
TOTAL BILIRUBIN 
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DIRECT: 
INDIRECT : 
SGOT : 
SGPT : 
CHEST XRAY :  
USG ABDOMEN: 
PaO2 
FiO2 
 
PaO2/FiO2 : 
  
104  
CONSENT FORM 
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KEY TO MASTER CHART 
 
BISAP- The Bedside Index for Severity in Acute Pancreatitis 
NEC- NECROSIS 
ARF- ACUTE RENAL FAILURE 
ARDS- ACUTE RESPIRATORY DISTRESS SYNDROME 
ENC- ENCEPHALOPATHY 
DIC- DISSEMINATED INTRAVASCULAR COAGULATION 
CYST- PSEUDOCYST 
ENC- ENCEPHALOPATHY 
GSD- GALL STONE DISEASE 
MODS- MULTI ORGAN DYSFUNCTION SYNDROME 
 
